Screener
Kyverna Therapeutics, Inc. KYTX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
FAQ
- What is Kyverna Therapeutics, Inc.'s shares (diluted)?
- Kyverna Therapeutics, Inc. (KYTX) reported shares (diluted) of 60.4M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Kyverna Therapeutics, Inc.'s shares (diluted) increased by 39.8% year-over-year, from 43.2M to 60.4M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s shares (diluted)?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s shares (diluted) has grown at a 676.6% compound annual growth rate (CAGR), from 2.9M to 174.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Kyverna Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude